全文获取类型
收费全文 | 36618篇 |
免费 | 3010篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 417篇 |
儿科学 | 1271篇 |
妇产科学 | 847篇 |
基础医学 | 4532篇 |
口腔科学 | 671篇 |
临床医学 | 5179篇 |
内科学 | 6609篇 |
皮肤病学 | 518篇 |
神经病学 | 3563篇 |
特种医学 | 1157篇 |
外科学 | 4195篇 |
综合类 | 757篇 |
一般理论 | 56篇 |
预防医学 | 4533篇 |
眼科学 | 611篇 |
药学 | 2640篇 |
2篇 | |
中国医学 | 34篇 |
肿瘤学 | 2083篇 |
出版年
2021年 | 551篇 |
2020年 | 368篇 |
2019年 | 564篇 |
2018年 | 634篇 |
2017年 | 495篇 |
2016年 | 540篇 |
2015年 | 634篇 |
2014年 | 921篇 |
2013年 | 1348篇 |
2012年 | 1842篇 |
2011年 | 1987篇 |
2010年 | 1068篇 |
2009年 | 843篇 |
2008年 | 1698篇 |
2007年 | 1865篇 |
2006年 | 1817篇 |
2005年 | 1777篇 |
2004年 | 1679篇 |
2003年 | 1565篇 |
2002年 | 1445篇 |
2001年 | 1020篇 |
2000年 | 1018篇 |
1999年 | 842篇 |
1998年 | 384篇 |
1997年 | 337篇 |
1996年 | 280篇 |
1995年 | 285篇 |
1994年 | 263篇 |
1993年 | 253篇 |
1992年 | 718篇 |
1991年 | 736篇 |
1990年 | 678篇 |
1989年 | 627篇 |
1988年 | 625篇 |
1987年 | 572篇 |
1986年 | 585篇 |
1985年 | 566篇 |
1984年 | 461篇 |
1983年 | 446篇 |
1982年 | 292篇 |
1981年 | 281篇 |
1980年 | 252篇 |
1979年 | 434篇 |
1978年 | 321篇 |
1977年 | 275篇 |
1976年 | 249篇 |
1975年 | 238篇 |
1974年 | 305篇 |
1973年 | 271篇 |
1972年 | 239篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
Clinical Spectrum of Capillary Malformation–Arteriovenous Malformation Syndrome Presenting to a Pediatric Dermatology Practice: A Retrospective Study
下载免费PDF全文
![点击此处可从《Pediatric dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Nicole A. Weitz M.D. Christine T. Lauren M.D. Gerald G. Behr M.D. June K. Wu M.D. Jessica J. Kandel M.D. Philip M. Meyers M.D. Sally Sultan M.D. Kwame Anyane‐Yeboa M.D. Kimberly D. Morel M.D. Maria C. Garzon M.D. 《Pediatric dermatology》2015,32(1):76-84
Capillary malformation–arteriovenous malformation syndrome (CM‐AVM) is an autosomal dominant disorder caused by RASA1 mutations. The prevalence and phenotypic spectrum are unknown. Evaluation of patients with multiple CMs is challenging because associated AVMs can be life threatening. The objective of this study was to describe the clinical characteristics of children presenting with features of CM‐AVM to an academic pediatric dermatology practice. After institutional review board approval was received, a retrospective chart review was performed of patients presenting between 2009 and 2012 with features of CM‐AVM. We report nine cases. Presenting symptoms ranged from extensive vascular stains and cardiac failure to CMs noted incidentally during routine skin examination. All demonstrated multiple CMs, two had Parkes Weber syndrome, and two had multiple infantile hemangiomas. Seven patients had family histories of multiple CMs; three had family histories of large, atypical CMs. Six had personal or family histories of AVMs. Genetic evaluation was recommended for all and was pursued by six families; four RASA1 mutations were identified, including one de novo. Consultations with neurology, cardiology, and orthopedics were recommended. Most patients (89%) have not required treatment to date. CM‐AVM is an underrecognized condition with a wide clinical spectrum that often presents in childhood. Further evaluation may be indicated in patients with multiple CMs. This study is limited by its small and retrospective nature. 相似文献
12.
13.
14.
15.
Nathan Scudder James Robertson Sally F. Kelty Simon J. Walsh Dennis McNevin 《The Australian journal of forensic sciences》2020,52(2):235-241
ABSTRACTForensic DNA analysis is dependent on comparing the known and the unknown. Expand the number of known profiles, and the likelihood of a successful match increases. Forensic use of DNA is moving towards comparing samples of unknown origin with publicly available genetic data, such as the records held by genetic genealogy providers. Use of forensic genetic genealogy has yielded a number of recent high-profile successes but has raised ethical and privacy concerns. Navigating family trees is complex, even more so when combined with a comparison of genetic relationships. This intelligence-gathering process has led to occasional false leads, and its use also risks a public backlash, similar to concerns over Cambridge Analytica. A cautious approach to use of this technique is therefore warranted. 相似文献
16.
17.
18.
Antony E. Shrimpton Robert L. Schelper Reinhold P. Linke John Hardy Richard Crook Dennis W. Dickson Takashi Ishizawa Richard L. Davis 《Neuropathology》2007,27(3):228-232
Over 100 mutations in the presenilin‐1 gene (PSEN1) have been shown to result in familial early onset Alzheimer disease (EOAD), but only a relatively few give rise to plaques with an appearance like cotton wool (CWP) and/or spastic paraparesis (SP). A family with EOAD, seizures and CWP was investigated by neuropathological study and DNA sequencing of the PSEN1 gene. Aβ was identified in leptomeningeal vessels and in cerebral plaques. A single point mutation, p.L420R (g.1508T > G) that gives rise to a missense mutation in the eighth transmembrane (TM8) domain of PS1 was identified in two affected members of the family. p.L420R (g.1508T > G) is the mutation responsible for EOAD, seizures and CWP without SP in this family. 相似文献
19.
20.
Paul A Dabisch Emily A Davis Michael S Horsmon Robert J Mioduszewski 《Journal of ocular pharmacology and therapeutics》2006,22(5):323-332
The organophosphorous nerve agent sarin (GB) and the carbamate pyridostigmine bromide (PB) both inhibit acetylcholinesterase (AChE), leading to overstimulation of muscarinic receptors. Both GB and PB produce miosis through stimulation of ocular muscarinic receptors. This study investigated 2 hypotheses: (1) that the miotic response to PB would decrease following repeated injections; and (2) that repeated administration of PB would result in tolerance to the miotic effect of GB vapor. Rats were injected intramuscularly with saline, 0.04 mg/kg, 0.5 mg/kg, or 1.4 mg/kg of PB twice daily for 8 consecutive days. After day 3, animals injected with 1.4 mg/kg PB developed miotic tolerance. Twenty-four (24) h following the final PB injection, the rats were exposed to GB vapor (4.0 mg/m(3)). A similar magnitude of miosis was observed in all groups after GB exposure. However, the rate of recovery of pupil size in animals pretreated with 0.5 and 1.4 mg/kg PB was significantly increased. Twenty (20) h following exposure to GB vapor, the pupils of animals pretreated with 1.4 mg/kg PB had recovered to 77% +/- 4% of their pre-exposure baseline, whereas the saline-injected controls had recovered to only 52% +/- 2% of their pre-exposure baseline. The increased rate of recovery does not appear to be a result of protection of pupillary muscarinic receptors by the higher doses of PB, as there was no longer PB present in the animal at the time of GB exposure. These results demonstrate the development of tolerance to the miotic effect of PB following repeated exposures, and also suggest that cross-tolerance between PB and GB occurs. However, because the magnitude of the response was not reduced, the PB pretreatment and its associated miotic cross-tolerance does not appear to diminish the effectiveness of miosis as a biomarker of acute exposure to nerve agent vapor. 相似文献